Open access · US-GOV via ClinicalTrials.gov Clinical trial

Association of Preoperative Sarcopenia on Postoperative Outcomes After Lung Cancer Surgery: Prospective Observational Study

Authors not listed

Seoul National University Hospital · 2021

Epigenetic alterations Human Randomized controlled trial

Abstract

The presence of sarcopenia before lung resection surgery might be an important factor of short-term and long-term prognosis in lung cancer patients. Through this study, investigators plan to demonstrate evidence whether sarcopenia is a useful clinical biomarker for risk stratification in elderly patients undergoing lung cancer surgery.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-12 MST

Cite this

APA

Anonymous. (2021). Association of Preoperative Sarcopenia on Postoperative Outcomes After Lung Cancer Surgery: Prospective Observational Study. <em>Seoul National University Hospital</em>. https://clinicaltrials.gov/study/NCT05346185

Vancouver

Anonymous. Association of Preoperative Sarcopenia on Postoperative Outcomes After Lung Cancer Surgery: Prospective Observational Study. Seoul National University Hospital. 2021.

BibTeX

@misc{anon2021Associ, title = {Association of Preoperative Sarcopenia on Postoperative Outcomes After Lung Cancer Surgery: Prospective Observational Study}, author = {Anonymous}, journal = {Seoul National University Hospital}, year = {2021}, }